Sandia Investment Management »

Iovance Biotherapeutics shares owned by Sandia Investment Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Sandia Investment Management from 13F filings

Historical chart of Sandia Investment Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Sandia Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Sandia Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $46k 10k 4.55

More positions owned by Sandia Investment Management

Haymaker Acquisition Corp Iv Class A (HYAC)
Bold Eagle Acquisition Corp Cl A (BEAG)
Fact Ii Acquisition Corp Ord Shs Cl A (FACT)
Live Oak Acquisition Corp V Cl A Shs (LOKV)
Regis Corporation Com Shs (RGS)
Webull Corp Ord Shs (BULL)
Bleichroeder Acquisition Cor Shs Cl A (BACQ)
Via Transn Com Cl A
Waterbridge Infrastructure L Cl A Shs Repstg
Loar Holdings Com Shs (LOAR)
Stonebridge Acquisition Ii C Unit 09/09/2030
Smithfield Foods Inc Common Stock Usd.5 (SFD)
Anterix Inc. Atex (ATEX)
Waystar Holding Corp (WAY)
Kodiak Gas Svcs (KGS)

View all positions for Sandia Investment Management

Top funds holding Iovance Biotherapeutics

MHR Fund Management
Vanguard Group
BlackRock
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Millennium Management
Dimensional Fund Advisors
Two Sigma Investments
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics